Filter
441
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
40
New Publications
140
Language
Document type
No document type
235
Studies & Reports
75
Guidelines
56
Manuals
30
Strategic & Response Plan
29
Training Material
6
Fact sheets
5
Situation Updates
3
Resource Platforms
2
Countries / Regions
Ethiopia
23
India
23
Kenya
19
Global
19
Uganda
12
Nepal
10
South Africa
10
Western and Central Europe
9
Nigeria
8
Zambia
8
Tanzania
8
Namibia
8
Liberia
7
Ghana
7
Philippines
7
Sierra Leone
6
Rwanda
6
Indonesia
6
Africa
5
Zimbabwe
4
Bangladesh
4
Malawi
4
Ukraine
4
Cameroon
3
South Sudan
3
Syria
3
Cambodia
3
Eswatini/ Swaziland
3
Myanmar / Burma
3
Eastern Europe and Central Asia
3
Eastern Europe
3
Burkina Faso
2
Senegal
2
Pakistan
2
Jordan
2
Thailand
2
Mozambique
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
South–East Asia Region
2
Fiji
2
Laos
2
Vietnam
2
Congo, Democratic Republic of
1
USA
1
Haiti
1
Somalia
1
Iraq
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Botswana
1
Libya
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Albania
1
Timor Leste/ East Timor
1
Lithuania
1
Moldova
1
Australia
1
Authors & Publishers
Publication Years
Category
Countries
205
Clinical Guidelines
25
Key Resources
24
Public Health
13
Pharmacy & Technologies
8
Women & Child Health
7
Capacity Building
5
Toolboxes
Pharmacy
48
AMR
35
COVID-19
21
NTDs
20
HIV
19
TB
19
Mental Health
17
Planetary Health
17
Rapid Response
12
Conflict
7
Health Financing Toolbox
7
Ebola
6
Caregiver
6
NCDs
6
Global Health Education
5
Disability
4
Specific Hazards
4
Refugee
3
Natural Hazards
2
Zika
1
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing war has caused large-scale disruptions to the deliv
...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth
...
https://doi.org/10.1371/journal.pntd.0002439
South Sudan has a high burden – among the highest in sub-Saharan Africa – of neglected tropical diseases (NTDs). This adversely affects the health and social and economic well-being of people in the country. The prevention, control and eventual elim
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect
...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
This report sets out ways to make pre-hospital care and ambulance services operating in areas of armed violence safer. Written by the Norwegian Red Cross with support from the ICRC and the Mexican Red Cross, the report summarizes field experience in over 20 countries.
